These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 27612218)

  • 21. Application of a diagnostic algorithm for the rare deficient variant Mmalton of alpha-1-antitrypsin deficiency: a new approach.
    Belmonte I; Barrecheguren M; López-Martínez RM; Esquinas C; Rodríguez E; Miravitlles M; Rodríguez-Frías F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2535-2541. PubMed ID: 27877030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of polymerase chain reaction and liver biopsy in the evaluation of patients with asymptomatic transaminitis: implications in diagnostic approach.
    Madan K; Batra Y; Panda SK; Dattagupta S; Hazari S; Jha JK; Acharya SK
    J Gastroenterol Hepatol; 2004 Nov; 19(11):1291-9. PubMed ID: 15482537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Liver biopsy in ambulatory patients. Diagnostic value in comparison to conventional and quantitative liver function tests].
    Giger A; Reichen J
    Schweiz Med Wochenschr; 1993 Jul; 123(30):1474-81. PubMed ID: 8367707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A polymorphism of the alpha1-antitrypsin gene represents a risk factor for liver disease.
    Chappell S; Hadzic N; Stockley R; Guetta-Baranes T; Morgan K; Kalsheker N
    Hepatology; 2008 Jan; 47(1):127-32. PubMed ID: 17972336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficient diagnostics for elevated transaminases].
    Folwaczny C
    MMW Fortschr Med; 2007 Jul; 149(29-30):44-8; quiz 49. PubMed ID: 17703692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Behavior of serum alpha 1-antitrypsin in chronic hepatopathies and its diagnostic significance].
    Tartaglino B; Macrì G; Molino G; Furlani D; Sansalvadore F
    Quad Sclavo Diagn; 1980 Dec; 16(4):451-8. PubMed ID: 6166021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Abnormal liver function tests in the primary care setting].
    Vinker S; Nakar S; Nir E; Hyam E; Weingarten MA
    Harefuah; 1998 Aug; 135(3-4):89-92, 168. PubMed ID: 9885647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidative radicals and liver involvement of infants with alpha-1-antitrypsin deficiency.
    Pittschieler K
    Padiatr Padol; 1991; 26(5):235-7. PubMed ID: 1663223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology.
    Skelly MM; James PD; Ryder SD
    J Hepatol; 2001 Aug; 35(2):195-9. PubMed ID: 11580141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement of serum alpha 1-acid glycoprotein and alpha 1-antitrypsin desialylation in liver disease.
    Serbource-Goguel N; Corbic M; Erlinger S; Durand G; Agneray J; Feger J
    Hepatology; 1983; 3(3):356-9. PubMed ID: 6601607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome.
    Sanyal AJ; Contos MJ; Sterling RK; Luketic VA; Shiffman ML; Stravitz RT; Mills AS
    Am J Gastroenterol; 2003 Sep; 98(9):2064-71. PubMed ID: 14499789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High prevalence of alpha-1-antitrypsin heterozygosity in children with chronic liver disease.
    Campbell KM; Arya G; Ryckman FC; Alonso M; Tiao G; Balistreri WF; Bezerra JA
    J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):99-103. PubMed ID: 17204961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular basis, clinical consequences and diagnosis of alpha-1 antitrypsin deficiency.
    Norman MR; Mowat AP; Hutchison DC
    Ann Clin Biochem; 1997 May; 34 ( Pt 3)():230-46. PubMed ID: 9158819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Utility of Liver Biopsy in the Evaluation of Liver Disease and Abnormal Liver Function Tests.
    Khalifa A; Lewin DN; Sasso R; Rockey DC
    Am J Clin Pathol; 2021 Jul; 156(2):259-267. PubMed ID: 33693456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hepatocellular carcinoma and the alpha 1-antitrypsin phenotype].
    Labadie H; Sesboué R; Martin JP; Beaugrand M
    Gastroenterol Clin Biol; 1985 Dec; 9(12):881-5. PubMed ID: 3007258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laboratory testing of individuals with severe alpha1-antitrypsin deficiency in three European centres.
    Miravitlles M; Herr C; Ferrarotti I; Jardi R; Rodriguez-Frias F; Luisetti M; Bals R
    Eur Respir J; 2010 May; 35(5):960-8. PubMed ID: 20436173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Case in Point: When Extended Genotyping of α-1 Antitrypsin (SERPINA1) is Indicated.
    Ricci KS; Kwong S; Stoller JK; Lacbawan F
    Appl Immunohistochem Mol Morphol; 2015; 23(10):744. PubMed ID: 25390356
    [No Abstract]   [Full Text] [Related]  

  • 38. Cluster headache and Alpha 1-antitrypsin deficiency.
    Summ O; Gregor N; Marziniak M; Gralow I; Husstedt IW; Evers S
    Cephalalgia; 2010 Jan; 30(1):113-7. PubMed ID: 19515129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterozygosity of alpha 1-antitrypsin: a health risk?
    Feld RD
    Crit Rev Clin Lab Sci; 1989; 27(6):461-81. PubMed ID: 2690855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating asymptomatic patients with abnormal liver function test results.
    Theal RM; Scott K
    Am Fam Physician; 1996 May; 53(6):2111-9. PubMed ID: 8623723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.